Titre : Relations interprofessionnelles

Relations interprofessionnelles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Relations interprofessionnelles : Questions médicales les plus fréquentes", "headline": "Relations interprofessionnelles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Relations interprofessionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relations interpersonnelles", "url": "https://questionsmedicales.fr/mesh/D007398", "about": { "@type": "MedicalCondition", "name": "Relations interpersonnelles", "code": { "@type": "MedicalCode", "code": "D007398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Relations médecin-infirmier", "alternateName": "Physician-Nurse Relations", "url": "https://questionsmedicales.fr/mesh/D019555", "about": { "@type": "MedicalCondition", "name": "Relations médecin-infirmier", "code": { "@type": "MedicalCode", "code": "D019555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401.205.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles", "alternateName": "Interprofessional Relations", "code": { "@type": "MedicalCode", "code": "D007400", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fatemeh Keshmiri", "url": "https://questionsmedicales.fr/author/Fatemeh%20Keshmiri", "affiliation": { "@type": "Organization", "name": "Associate Professor, Medical Education Department, Education Development Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran." } }, { "@type": "Person", "name": "Erin Abu-Rish Blakeney", "url": "https://questionsmedicales.fr/author/Erin%20Abu-Rish%20Blakeney", "affiliation": { "@type": "Organization", "name": "School of Nursing, University of Washington , Seattle , WA , USA." } }, { "@type": "Person", "name": "Azam Hosseinpour", "url": "https://questionsmedicales.fr/author/Azam%20Hosseinpour", "affiliation": { "@type": "Organization", "name": "Instructor, Department of Operating Room, School of Allied Medical Sciences, Qom University of Medical Sciences, Qom, Iran." } }, { "@type": "Person", "name": "Katja Krug", "url": "https://questionsmedicales.fr/author/Katja%20Krug", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de." } }, { "@type": "Person", "name": "Michel Wensing", "url": "https://questionsmedicales.fr/author/Michel%20Wensing", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37098622", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12969-023-00819-6" } }, { "@type": "ScholarlyArticle", "name": "Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35814764", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmed.2022.945691" } }, { "@type": "ScholarlyArticle", "name": "Evans' syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36483231", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4081/dr.2022.9470" } }, { "@type": "ScholarlyArticle", "name": "Juvenile Scleroderma.", "datePublished": "2023-11-15", "url": "https://questionsmedicales.fr/article/37966656", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12098-023-04894-1" } }, { "@type": "ScholarlyArticle", "name": "A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma.", "datePublished": "2024-01-01", "url": "https://questionsmedicales.fr/article/38364378", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5826/dpc.1401a23" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Relations interpersonnelles", "item": "https://questionsmedicales.fr/mesh/D007398" }, { "@type": "ListItem", "position": 4, "name": "Relations interprofessionnelles", "item": "https://questionsmedicales.fr/mesh/D007400" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Relations interprofessionnelles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Relations interprofessionnelles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Relations interprofessionnelles", "description": "Comment évaluer la communication interprofessionnelle ?\nQuels indicateurs mesurent la collaboration interprofessionnelle ?\nQuels outils facilitent le diagnostic interprofessionnel ?\nComment identifier les barrières à la collaboration ?\nQuel rôle joue la culture organisationnelle dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Relations interprofessionnelles", "description": "Quels symptômes indiquent une mauvaise communication ?\nComment reconnaître un manque de collaboration ?\nQuels symptômes affectent la dynamique d'équipe ?\nQuels signes montrent une bonne collaboration ?\nComment les symptômes de stress impactent-ils les relations ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Relations interprofessionnelles", "description": "Comment prévenir les conflits interprofessionnels ?\nQuelles stratégies améliorent la prévention des erreurs ?\nComment sensibiliser à l'importance de la collaboration ?\nQuels outils aident à la prévention des erreurs médicales ?\nComment la prévention impacte-t-elle les soins ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Relations interprofessionnelles", "description": "Comment améliorer les traitements par la collaboration ?\nQuels traitements favorisent la communication ?\nComment évaluer l'efficacité des traitements interprofessionnels ?\nQuels traitements sont adaptés aux équipes interprofessionnelles ?\nComment les traitements peuvent-ils être personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Relations interprofessionnelles", "description": "Quelles complications résultent d'une mauvaise communication ?\nComment les conflits affectent-ils les résultats des soins ?\nQuelles complications peuvent survenir en cas de mauvaise collaboration ?\nComment évaluer l'impact des complications sur les soins ?\nQuelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Relations interprofessionnelles", "description": "Quels facteurs augmentent le risque de conflits ?\nComment le stress influence-t-il les relations interprofessionnelles ?\nQuels facteurs de risque sont liés à la collaboration ?\nComment les différences de statut affectent-elles les relations ?\nQuels facteurs environnementaux influencent la collaboration ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la communication interprofessionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des outils d'évaluation comme des questionnaires et des entretiens." } }, { "@type": "Question", "name": "Quels indicateurs mesurent la collaboration interprofessionnelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent la satisfaction des patients et l'efficacité des soins." } }, { "@type": "Question", "name": "Quels outils facilitent le diagnostic interprofessionnel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des plateformes de partage d'informations et des réunions d'équipe." } }, { "@type": "Question", "name": "Comment identifier les barrières à la collaboration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes et des discussions en groupe pour recueillir des retours d'expérience." } }, { "@type": "Question", "name": "Quel rôle joue la culture organisationnelle dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une culture ouverte favorise la communication et la collaboration entre les professionnels." } }, { "@type": "Question", "name": "Quels symptômes indiquent une mauvaise communication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs médicales fréquentes et des plaintes des patients peuvent en être des signes." } }, { "@type": "Question", "name": "Comment reconnaître un manque de collaboration ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits fréquents et un manque de coordination dans les soins sont des indicateurs." } }, { "@type": "Question", "name": "Quels symptômes affectent la dynamique d'équipe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la frustration et le turnover élevé peuvent affecter la dynamique d'équipe." } }, { "@type": "Question", "name": "Quels signes montrent une bonne collaboration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une communication fluide et des résultats positifs pour les patients sont des signes clés." } }, { "@type": "Question", "name": "Comment les symptômes de stress impactent-ils les relations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut mener à des conflits et à une communication inefficace entre les professionnels." } }, { "@type": "Question", "name": "Comment prévenir les conflits interprofessionnels ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par des formations régulières sur la communication et la gestion des conflits." } }, { "@type": "Question", "name": "Quelles stratégies améliorent la prévention des erreurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles clairs et des revues de cas régulières." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance de la collaboration ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des séminaires et des ateliers sur les bénéfices de la collaboration interprofessionnelle." } }, { "@type": "Question", "name": "Quels outils aident à la prévention des erreurs médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les check-lists et les systèmes de double vérification sont des outils efficaces." } }, { "@type": "Question", "name": "Comment la prévention impacte-t-elle les soins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne prévention réduit les erreurs et améliore la satisfaction des patients." } }, { "@type": "Question", "name": "Comment améliorer les traitements par la collaboration ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "En intégrant des équipes multidisciplinaires pour une approche globale des soins." } }, { "@type": "Question", "name": "Quels traitements favorisent la communication ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des formations en communication et des ateliers de team-building sont bénéfiques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements interprofessionnels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Par des études de cas et des analyses de résultats cliniques post-traitement." } }, { "@type": "Question", "name": "Quels traitements sont adaptés aux équipes interprofessionnelles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements complexes comme la gestion de la douleur nécessitent une approche collaborative." } }, { "@type": "Question", "name": "Comment les traitements peuvent-ils être personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En tenant compte des compétences et des expertises de chaque professionnel de santé." } }, { "@type": "Question", "name": "Quelles complications résultent d'une mauvaise communication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs de traitement et des retards dans les soins peuvent survenir." } }, { "@type": "Question", "name": "Comment les conflits affectent-ils les résultats des soins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits peuvent mener à des soins fragmentés et à une insatisfaction des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de mauvaise collaboration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications médicales et des réadmissions fréquentes peuvent en résulter." } }, { "@type": "Question", "name": "Comment évaluer l'impact des complications sur les soins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses de données sur les résultats cliniques et la satisfaction des patients." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise dynamique peut entraîner un turnover élevé et une baisse de la qualité des soins." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de conflits ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des différences culturelles et des styles de communication variés peuvent augmenter les conflits." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les relations interprofessionnelles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut réduire la communication et augmenter les tensions entre les professionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque sont liés à la collaboration ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un manque de formation et des horaires de travail chargés peuvent nuire à la collaboration." } }, { "@type": "Question", "name": "Comment les différences de statut affectent-elles les relations ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les différences de statut peuvent créer des déséquilibres et des tensions dans l'équipe." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent la collaboration ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement de travail positif et des ressources adéquates favorisent la collaboration." } } ] } ] }

Sources (10000 au total)

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.

Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permane... In this cross-sectional study, caregivers of juvenile LS or SSc patients were recruited from a virtual family scleroderma educational conference and a juvenile scleroderma online interest group. The s... The response rate was 61% (73/120), with 38 parents of LS patients and 31 parents of SSc patients. Most patients were female (80%) and over half were non-Hispanic white (55%). Most families had at lea... Caregivers of children with LS or SSc reported numerous common barriers to the diagnosis, treatment, and ongoing care of juvenile scleroderma. The major problem highlighted was the lack of knowledge o...

Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study.

Microcirculation plays a vital role in scleroderma physiopathology and the mechanism of fat survival.... This study aims to assess the blood perfusion change after fat grafting and evaluate the relationship between blood perfusion and fat graft retention in patients with localized scleroderma (LS).... A pilot study was conducted in patients with LS receiving autologous fat grafting (AFG). Fat graft retention measured by magnetic resonance imaging (MRI) analysis and blood flow perfusion measured by ... The fat retention at the 6-month follow-up was 34.56 ± 11.89 percent. At the 6th month of follow-up, the relative blood perfusion at the lesion area was 115.08 ± 14.39 PU, significantly higher than 10... Local blood perfusion in the lesion area relatively increased after AFG, but no direct relationship was found between fat retention and increased blood supply....

Juvenile Scleroderma.

Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-dis...

A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma.

Morphea localized scleroderma (LS) is a rare skin disease with unknown pathogenesis, which causes sclerosis of the dermis and subcutaneous tissue.... It was aimed to compare the characteristics of patients with pediatric and adult-onset morphea.... A retrospective analysis was performed on the records of 183 adult morphea patients. The demographics, clinical and laboratory characteristics, and treatment options of the patients were recorded. Adu... Twenty-two percent (N = 41) of the patients had pediatric-onset morphea (POLS) and 77.6% (n=142) had adult-onset morphea (AOLS). While POLS had a higher head-neck involvement, AOLS had a higher breast... Clinical characteristics and accompanying laboratory anomalies of the patients with morphea depend on the age of onset, involvement areas and the types of morphea, having such data readily available s...

Human otopathology in scleroderma.

Scleroderma is a complex chronic progressive immune-mediated disease that causes fibrosis of the skin and internal organs, and vasculopathy.Ear involvement has been poorly studied in patients with scl... The national temporal bone database was reviewed for cases with scleroderma. Clinical case review and correlative otopathologic analysis. Middle and inner ear otopathologic analysis was performed foll... Two patients (three cases) with a history of serologically confirmed scleroderma were identified. Both individuals reported tinnitus and demonstrated bilateral moderate to severe down-sloping sensorin... Fibrosis, inflammation, and vascular changes were observed in the middle and inner ear in patients with scleroderma. Findings have implications for understanding hearing and vestibular dysfunction in ... Retrospective study....

Tracking Fat Grafts by Magnetic Resonance Imaging: A Comparative Study of Adolescent and Adult Patients with Stable Localized Scleroderma.

The optimal timing of reconstruction for patients with facial localized scleroderma is uncertain. The purpose of this study was to compare the outcomes of autologous fat transplantation in adolescent ... Adolescent (age 10-19 years) and adult (age >19 years) patients with no previous surgery were enrolled (n = 10, each group). Preoperative magnetic resonance imaging (MRI), blood tests and dermatologic... There was no significant difference in sex, body mass index, disease severity, or volume of injected fat between the two groups (p > 0.05), except for age (p < 0.05). The one-year postoperative fat gr... In stable localized scleroderma, the initial autologous fat transplantation was equally effective for facial contour deformity improvement, with no significant difference in fat graft retention or sat...